Rekha Gyanchandani
Rekha Gyanchandani
Postdoctoral Associate
Verified email at
Cited by
Cited by
Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients
P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ...
Clinical cancer research 22 (5), 1130-1137, 2016
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
A Argiris, AP Kotsakis, T Hoang, FP Worden, P Savvides, MK Gibson, ...
Annals of oncology 24 (1), 220-225, 2013
Tumor-infiltrating lymphocytes: a predictive and prognostic biomarker in neoadjuvant-treated HER2-positive breast cancer
BI Heppner, M Untch, C Denkert, BM Pfitzner, B Lederer, W Schmitt, ...
Clinical Cancer Research 22 (23), 5747-5754, 2016
Circulating Tumor Cell Phenotyping via High‐Throughput Acoustic Separation
M Wu, PH Huang, R Zhang, Z Mao, C Chen, G Kemeny, P Li, AV Lee, ...
Small 14 (32), 1801131, 2018
A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma
R Gyanchandani, MVO Alves, JN Myers, S Kim
Molecular Cancer Research 11 (12), 1585-1596, 2013
Intratumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer
R Gyanchandani, Y Lin, HM Lin, K Cooper, DP Normolle, A Brufsky, ...
Clinical Cancer Research 22 (21), 5362-5369, 2016
Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole
R Gyanchandani, KJ Kota, AR Jonnalagadda, T Minteer, BA Knapick, ...
Oncotarget 8 (40), 66901, 2017
Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma
R Gyanchandani, D Sano, MVO Alves, JD Klein, BA Knapick, S Oh, ...
Oral oncology 49 (8), 761-770, 2013
Targeted mutation detection in breast cancer using MammaSeq™
NG Smith, R Gyanchandani, OS Shah, GT Gurda, PC Lucas, ...
Breast Cancer Research 21 (1), 1-11, 2019
Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood
R Gyanchandani, E Kvam, R Heller, E Finehout, N Smith, K Kota, ...
Scientific reports 8 (1), 1-12, 2018
Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkers
DM Spagnolo, R Gyanchandani, Y Al-Kofahi, AM Stern, TR Lezon, ...
Journal of pathology informatics 7, 2016
Predictive biomarkers to anti-VEGF therapy: progress toward an elusive goal
R Gyanchandani, S Kim
Clinical Cancer Research 19 (4), 755-757, 2013
intratumor heterogeneity: Biological and clinical implications
R Gyanchandani, N Priedigkeit, A Basudan, AV Lee
Oncogenomics, 17-30, 2019
Tumor Cell Phenotyping: Circulating Tumor Cell Phenotyping via High‐Throughput Acoustic Separation (Small 32/2018)
M Wu, PH Huang, R Zhang, Z Mao, C Chen, G Kemeny, P Li, AV Lee, ...
Small 14 (32), 1870145, 2018
Detection and functional analysis of estrogen receptor mutations (ESR1-mut) in patients with metastatic breast cancer (MBC).
S Puhalla, P Wang, A Bahreini, R Gyanchandani, TF Ambros, ...
Journal of Clinical Oncology 33 (15_suppl), 554-554, 2015
Targeted Mutation Detection in Advanced Breast Cancer Using MammaSeq Identifies RET as a Potential Contributor to Breast Cancer Metastasis
N Smith, R Gyanchandani, N Priedigkeit, RJ Hartmaier, Y Chen, G Gurda, ...
University of Pittsburgh, 2018
Polyploid tumor cells: a chemoresistant cell type in triple-negative breast cancer
R Gyanchandani, A Lee
Cancer Research 77 (13 Supplement), 2050-2050, 2017
cfDNA mutation frequency in early stage breast cancer.
KJ Kota, R Gyanchandani, MQ Rosenzweig, A Brufsky, ...
Journal of Clinical Oncology 35 (15_suppl), e23047-e23047, 2017
Abstract P6-07-07: ESR1 amplification and 5'-3'exon imbalance in metastatic breast cancer
S Oesterreich, A Basudan, N Preideigkeit, RJ Hartmaier, A Bahreini, ...
Cancer Research 77 (4 Supplement), P6-07-07-P6-07-07, 2017
Palbociclib's effect on estrogen receptor mutations in metastatic breast cancer.
KJ Kota, R Gyanchandani, A Brufsky, AV Lee, S Oesterreich, S Puhalla
Journal of Clinical Oncology 34 (15_suppl), 533-533, 2016
The system can't perform the operation now. Try again later.
Articles 1–20